China wholesale Treatment Of Hepatitis C - USP 175865-59-5 Valganciclovir hydrochloride for Antiviral – Yibai
China wholesale Treatment Of Hepatitis C - USP 175865-59-5 Valganciclovir hydrochloride for Antiviral – Yibai Detail:
Product name | Valganciclovir hydrochloride |
Synonyms | L-Valine,2-[(2-aMino-1,6-dihydro-6-oxo-9H-purin-9-yl)Methoxy]-3-hydroxypropylester,hydrochloride(1:1);2-[(2-amino-6-oxo-6,9-dihydro-3H-purin-9-yl)methoxy]-3-hydroxypropyl(2S)-2-amino-3-methylbutanoatehydChemicalbookrochloridehydrate;L-Valine,2-[(2-amino-1,6-dihydro-6-oxo-9H-purin-9-yl)methoxy]-3-hydroxypropylester,monohydrochloridehydrate |
CAS No. | 175865-59-5 |
Appearance | White or off-white crystalline powder |
Molecular Formula | C14H22N6O5.HCl |
Molecular Weight | 390.83 |
Usage | Pharmaceutical Grade or Research purpose |
Packing | As per your request |
Storage | Preserve in tight,light-resistant containers in a cool place |
Valganciclovir hydrochloride Cas: 175865-59-5 |
||
Items |
Standard |
Results |
Appearance | White or off-white crystalline powder | white powder |
Identification | Infrared Absorption:Corresponds to that of reference standardUltraviolet Absorption:Corresponds to that of reference standardA solution in water (1 in 20) meets the requirements of the tests for Chloride | Complies Complies
Complies |
Isopropyl alcohol | ≤1.0% | 0.13% |
Water | ≤8.0% | 4.5% |
Heavy metals | ≤20ppm | Complies |
Pd | ≤10ppm | <10ppm |
Residue on ignition | ≤0.1% | 0.02% |
Related impurities | Valganciclovir: /Ganciclovir: ≤1.5%Guanine: ≤1.5%
Methoxymethylguanine: ≤0.3% Isovalganciclovir: ≤0.5% Monoacetoxyganciclovir: ≤0.15% Bis-valine easter of ganciclovir: ≤0.1% Homologue of valganciclovir: ≤0.25% Imp H: ≤0.1% Imp I: ≤0.1% Ganciclovir monopropionate: ≤0.15% Valganciclovir dimer (stereoisomer A): ≤0.1% Valganciclovir dimer (stereoisomer B): ≤0.1% Valganciclovir dimer (stereoisomer C): ≤0.1% Single other identified impurity: ≤0.1% Total other identified impurity: ≤0.1% Ganciclovir mono-N-methyl valinate (Test 2):≤0.3% Single unidentified impurity (Test 1 and 2): ≤0.1 % Total unidentified impurity (Test 1 and 2): ≤0.25% Total impurities (Test 1 and Test 2): ≤3.0 |
/0.02%0.01%
0.03% 0.02% ND 0.04% 0.01% 0.01% 0.004% ND ND ND ND Max 0.04% 0.04%
0.02% Max 0.02% 0.13% 0.78% |
Diastereomer ratio | 45:55 to 55:45 | 54:46 |
Enantiomeric purity of valganciclovir | ≥97.0% | 99.9% |
HPLC assay | 97.0%~102.0% | 98.8% |
Conclusion: complies with USP40. |
Company Information
√ Management layer’s full experience in factory and skilled technicians followers; √ Quality is always our top consideration, Strict QC system; √ 11 years experienced exporting sales team; √ Independent R&D lab; √ Two signed long term GMP workshops; √ Rich resources of plenty idle factories for customized project; √ High Efficiency working team with consistent path.Product detail pictures:
Related Product Guide:
Trustworthy good quality and excellent credit score standing are our principles, which will help us at a top-ranking position. Adhering towards the tenet of "quality first, buyer supreme" for China wholesale Treatment Of Hepatitis C - USP 175865-59-5 Valganciclovir hydrochloride for Antiviral – Yibai , The product will supply to all over the world, such as: Portugal, Hanover, Moldova, Our company will adhere to "Quality first, , perfection forever, people-oriented , technology innovation"business philosophy. Hard work to keep making progress, innovation in the industry, make every effort to first-class enterprise. We try our best to build the scientific management model, to learn abundant skilled knowledge, to develop advanced production equipment and production process , to create the first-call quality solutions, reasonable price , high quality of service , quick delivery , to offer you create new value .
By Princess from Bahamas - 2018.12.11 11:26
Company director has very rich management experience and strict attitude, sales staff are warm and cheerful, technical staff are professional and responsible,so we have no worry about product,a nice manufacturer.
By Mamie from Sevilla - 2017.10.13 10:47